Pharmacokinetic Modeling Enhanced by Deep Learning

Physiologically Based Pharmacokinetic (PBPK) modeling is a cornerstone of drug development, enabling the prediction of drug absorption, distribution, metabolism, and excretion (ADME). However, widespread adoption is hindered by high computational costs, difficulty in parameter identification, and uncertainties in interspecies extrapolation.

A new study proposes a unified Scientific Machine Learning (SciML) framework that combines mechanistic rigor and data-driven flexibility. The framework introduces three key elements:

  • Foundation PBPK Transformers: treat pharmacokinetic forecasting as a sequence modeling task.
  • Physiologically Constrained Diffusion Models (PCDM): a generative approach that uses a physics-informed loss to synthesize biologically compliant virtual patient populations.
  • Neural Allometry: a hybrid architecture combining Graph Neural Networks (GNNs) with Neural ODEs to learn continuous cross-species scaling laws.

Experimental results on synthetic datasets show that the framework reduces physiological violation rates from 2.00% to 0.50% under constraints, paving the way for faster simulations.